SEZARY-SYNDROME ASSOCIATED WITH PHENYTOIN THERAPY

被引：0

作者：

DOYLE, MF ^{[1
]}

ANDERSON, S ^{[1
]}

CERREZUELA, C ^{[1
]}

GABRAIL, N ^{[1
]}

机构：

[1] TIMKEN MERCY MED CTR, DEPT ONCOL, CANTON, OH 44708 USA

来源：

关键词：

PHENYTOIN; SEZARY SYNDROME;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Clinical, laboratory and molecular biological features are presented from a pa

引用

页码：204 / 207

页数：4

共 27 条

[1]

ADAMS J D, 1981, Australasian Journal of Dermatology, V22, P28, DOI 10.1111/j.1440-0960.1981.tb00775.x

[2]

ANDERSON VM, 1979, CUTIS, V23, P493

CHARLESWORTH, EN .

[4]

COHNEN G, 1977, MUNCHEN MED WOCHEN, V119, P309

[5]

COOKE LE, 1988, CLIN PHARMACY, V7, P153

[6]

DANNO K, 1989, Journal of Dermatology (Tokyo), V16, P392

[7]

GYTE GML, 1985, SCAND J HAEMATOL, V35, P358

[8]

HOPPE RT, 1990, CURR PROB CANCER, V14, P295

HYMAN, GA ;

SOMMERS, SC .

BLOOD-THE JOURNAL OF HEMATOLOGY, 1966, 28 (03) :416-&

[10]

ISOBE T, 1980, ACTA HAEMATOL JAPON, V43, P711